ARCHIVES

In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div.

This article is from The Cancer Letter archive.

Vol. 18 No. 09 | February 28, 1992

Download PDF Visit The Full Archive

Related Articles

DCPC Board Agrees to Commit $62 Million To Trials Of Prostate, Lung, Colorectal Cancer Screening

October 20, 1989

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

FCRC Committee Limited To Review Of Basic Science

November 26, 1976

FY09 Proposal for NIH Flat. NCI “Bypass Budget” Makes Case for $6 Billion.

February 8, 2008

Organization Can Compete For Both Major FCRC Contracts, RFP Out Next June

September 12, 1980

In Their Own Words: “Blessed with The Opportunity” vs. “LOWEST Morale Ever”

May 23, 2014